889
Portal Fibrosis during Acute HCV Infection of HIV-infected Men
Daniel Fierer*, A Uriel, D Carriero, A Klepper, D Dieterich, M Mullen, S Thung, I Fiel, and A Branch
Mt Sinai Sch of Med, New York, NY, US
Background: Multiple outbreaks of acute hepatitis C virus
(HCV) infection have recently been reported in HIV-infected men who have sex with
men (MSM). The extent of liver disease
in these patients is unknown and is of concern.
Methods: After providing informed consent, we
enrolled in a prospective study of acute HCV infection, 4 consecutive
HIV-infected MSM referred to Mount Sinai for the treatment of acute HCV infection.
Results: All 4 patients had acute HCV
infection confirmed using the following criteria (see the table): alanine aminotransferase (ALT) elevations of >10 x ULN, HCV
antibody seroconversion, and widely fluctuating HCV viral
load; all had clinical and laboratory findings consistent with previously
reported cases of acute HCV in HIV+ MSM. Liver biopsy performed within 5 months of
presentation with elevated ALT levels, surprisingly, showed moderate portal
fibrosis (stage 2 of 4; Scheuer) in 3 of the 4
patients (1, 2, and 3), as well as the expected findings of acute viral
hepatitis in all patients; moderate central hyalin
sclerosis was found in patient 4. All patients had negative evaluations for hepatitis
A virus (HAV) and hepatitis B virus (HBV); all denied heavy alcohol use; and 1
had never received ART. No cause of chronic liver disease common to all
patients could be identified to explain the fibrosis.
Conclusions: Of 4 consecutively evaluated HIV-infected MSM
with acute HCV infection, 3 unexpectedly had moderately advanced portal
fibrosis on liver biopsy; the fourth had central hyalin
sclerosis. No other cause of liver injury was identified; therefore either
fibrosis during acute HCV infection is greatly accelerated by pre-existing HIV
infection, or chronic liver disease of unknown etiology predated the acute HCV
infection in these men. These cases suggest that HIV-infected patients
presenting with acute HCV infection may already have significant liver disease,
and that liver biopsy should therefore be considered in these patients.
1at presentation
|
|
Patient
1
|
Patient
2
|
Patient
3
|
Patient
4
|
|
Age (years)
|
40
|
47
|
40
|
47
|
|
Duration HIV diagnosis
|
4 years
|
13 years
|
17 years
|
11 months
|
|
CD4 count (cells/μL)1
|
720
|
303
|
241
|
697
|
|
HIV
viral load (log10 copies/mL)1
|
<1.7
|
5.2
|
2.9
|
<1.7
|
|
ART history
|
3 years;
no ddI/d4T
|
never
|
17 years;
past ddI/d4T
|
11 months;
no ddI/d4T
|
|
Peak ALT (U/mL)
|
1,164
|
1,620
|
567
|
1,880
|
|
HCV viral load fluctuation
|
1.1 log in 2 week
|
2 log in 12 week
|
1.7 log in 4 week
|
2.8 log in 2 week
|
|
HCV seroconversion
(mo)
|
4
|
27
|
34
|
11
|
|
HCV genotype
|
1a
|
1a
|
1b
|
1a
|
|
Pathological diagnosis
|
stage 2 fibrosis
|
stage 2 fibrosis
|
stage 2 fibrosis
|
central hyalin sclerosis
|
|